Guardant Health
GH
#1530
Rank
โ‚ฌ11.61 B
Marketcap
89,45ย โ‚ฌ
Share price
2.11%
Change (1 day)
159.85%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -2,89ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -2,76ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,06ย โ‚ฌ an increase over its 2023 EPS that were of -3,68ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,89ย โ‚ฌ-5.6%
2024-3,06ย โ‚ฌ-16.82%
2023-3,68ย โ‚ฌ-33.13%
2022-5,50ย โ‚ฌ60%
2021-3,43ย โ‚ฌ55.04%
2020-2,22ย โ‚ฌ207.14%
2019-0,72ย โ‚ฌ-19.81%
2018-0,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-1,84ย โ‚ฌ-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-4,13ย โ‚ฌ 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA